Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: former_pgs who wrote (3561)	11/17/2005 11:20:49 AM
From: tom pope	Read Replies (1) \| Respond to of 12215

Very plausible. I'd never thought of TELK as a momentum stock, but that sudden run does have the hallmarks, doesn't it. FWIW, I have it on my potential take over screen, but I can't remember now why I put it there. I'll be guided by the action at the close to decide whether to bail or not. It used to be one of my faves but I disembarked about a year or more ago

To: former_pgs who wrote (3561)	11/17/2005 4:51:42 PM
From: marthambles	Respond to of 12215

Maybe it is a momentum play. Or just maybe the market is recognizing the dovetailing of information leading to the conclusion that the probablility of Telk having two blockbuster drugs has risen dramatically with the release of the Telintra abstract and the realization of the liklihood that Telcyta was extending the survival rates in ovarian and lung. Did you hear the questioner at the CSFB conference practically implore Wick to acknowledge that the delay in "event" occurrence must mean that Telcyta is working?